Thyrocare Technologies Limited has informed the Exchange about Resignation of Director/KMP/SMP
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.9 pts more than Nifty Microcap 250 and 1.4 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Thyrocare Technologies announced resignations of two Non-Executive Non-Independent Directors effective May 7, 2026. Mr. Dharmil Nirupam Sheth (DIN: 06999772) and Mr. Dhaval Rajesh Shah (DIN: 07485688) both cited preoccupation and other professional commitments as reasons for their departures. Sheth served on the Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Risk Management Committee, while Shah served on the Corporate Social Responsibility Committee. Both directors confirmed no material reason for resignation other than stated. The company simultaneously appointed two new Non-Executive Non-Independent Directors — Mr. Uday Patel Kadam (COO & CBO at API Holdings) and Mr. Gaurav Verma ( CBO at API Holdings/PharmEasy) — effective May 8, 2026. Statutory auditor Price Waterhouse Chartered Accountants LLP and cost auditor Jitender Navneet & Co. were also appointed.
The resignation of two board members on the same day citing professional commitments could signal governance changes or strategic shifts. However, simultaneous appointment of two industry-experienced directors from API Holdings suggests continuity and potential new strategic direction, particularly given their healthcare and technology background.